PATENT CLAIM ANALYSIS

Application Number: 15743601
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "157000"]

Abstract:
Disclosed herein are compounds having the following structure useful as inhibitors of carbonic anhydrase IX (CAIX) and XII, and particularly useful for reducing or eliminating metastases see Formula (I).

Claim (Index 2):
The compound of Formula (I), wherein n is 1, and R 2 , R 3 , R 4 , R 5  are each hydrogen, and is represented by a structure of Formula (Ia): wherein: R 1  is alkyl, cycloalkyl, cycloalkylalkyl, haloalkyl, aryl, heterocyclyl, heteroaryl, or alkoxy; R 6 , R 7 , R 8 , and R 9  are the same or different and independently hydrogen, alkyl, cycloalkyl, cycloalkylalkyl, amino, halo, or haloalkyl; L is a direct bond or)(C(R 10 ) 2 ) p ; p=1 to 4; and each R 10  is the same or different and independently hydrogen or alkyl; a stereoisomer, enantiomer or tautomer thereof, an isotopically enriched derivative thereof, a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof or a prodrug thereof, provided that the compound of Formula (I) is not 4-[3-[cis-4-(aminomethyl)-4-[3-chlorophenyl)cyclohexyl]-2-oxo-1-imidazolidinyl]-benzenesulfonamide.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.12903
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14795837', '14355552', '13737704', '15631417', '12695636']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7882673581394325
- 35 USC 102 Novelty (BERT): 0.5027924971784742
- Combined Prediction Score: 0.7597198720433367
- Mean Citation Score: 267.4747
- Max Citation Score: 280.91833
- Similarity Product: 232.29377971863275

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test